Surgical management of patients with peritonea carcinomatosis of gastrointestinal origin = Chirurgische Behandlung von peritoneal disseminierten gastrointestinalen Tumoren

Iesalnieks, I. and Kullmann, F. and Dahlke, M. and Ghali, N. and Agha, A. and von Breitenbuch, P. and Schoelmerich, J. and Schlitt, H. J. and Piso, P. (2006) Surgical management of patients with peritonea carcinomatosis of gastrointestinal origin = Chirurgische Behandlung von peritoneal disseminierten gastrointestinalen Tumoren. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 44 (12). pp. 1237-1245. ISSN 0044-2771

Full text not available from this repository. (Request a copy)

Abstract

Peritoneal carcinomatosis is found in approximately 15% of patients with colorectal cancer during the course of their disease, and is associated with a poor prognosis. Even more patients with gastric cancer develop peritoneal seeding. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) have been introduced in the past decade and have led to 5-year survival rates of 30 to 40% for selected patients with colorectal cancer and peritoneal carcinomatosis. These numbers have been demonstrated by many retrospective analyses and by prospective Phase 11 studies. The clinical assessment to select patients who will benefit from the combined therapy and achievement of complete macroscopic cytoreduction both play a crucial role. Less favourabale results have been achieved for patients suffering from stage IV gastric cancer with peritoneal seeding. Promising results were demonstrated for postoperative intraperitoneal chemotherapy following curative gastrectomy. Patients with hepatic, biliary and pancreatic cancers and peritoneal carcinomatosis do not benefit from cytoreductive surgery. There is a need for further multi-centre, prospective trials analysing the use of hyperthermic intraperitoneal chemotherapy. They should be conducted in the specialised centres by interdisciplinary teams.

Item Type: Article
Uncontrolled Keywords: HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; GASTRIC-CANCER PATIENTS; LONG-TERM SURVIVAL; QUALITY-OF-LIFE; CYTOREDUCTIVE SURGERY; PSEUDOMYXOMA-PERITONEI; COLORECTAL-CANCER; PROGNOSTIC-FACTORS; SEROSAL INVASION; RANDOMIZED-TRIAL; peritonectomy; peritoneal carcinomatosis; colorectal cancer; gastric cancer; pseudomyoxoma
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 04 Mar 2021 06:53
Last Modified: 04 Mar 2021 06:53
URI: https://pred.uni-regensburg.de/id/eprint/33743

Actions (login required)

View Item View Item